Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis
Anticoagulants are the mainstay for the prevention and treatment of thrombosis. However, bleeding complications remain a primary concern. Recent advances in understanding the contribution of activated factor XI (FXIa) in arterial thrombosis with a limited impact on hemostasis have led to the develop...
Saved in:
Main Author: | Wichaiyo S. |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/88084 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Clinical differentiation between acute arterial embolism and acute arterial thrombosis of the lower extremities
by: Pramook Mutirangura, et al.
Published: (2018) -
The effect of small molecule inhibitors on ciliogenesis
by: Chan, Lovynn Wan Ting
Published: (2017) -
CHARACTERIZATION OF A NOVEL INHIBITOR OF COAGULATION FACTOR XIA IDENTIFIED FROM SALIVARY GLAND TRANSCRIPTS OF THE LONE STAR TICK, AMBLYOMMA AMERICANUM
by: Mrinalini, et al.
Published: (2021) -
A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma
by: Zhang, M., et al.
Published: (2021) -
Pharmacophore modeling for the identification of small-molecule inhibitors of TACE
by: Liu, Li-Juan, et al.
Published: (2016)